SCHEMBL2762507

SCHEMBL2762507

CCN(C(=O)c1ccccc1)N(C)Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ HDAC1 Q13547 3/20 0.49
▸ HDAC6 Q9UBN7 3/20 0.49
▸ TSHR P16473 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ PPARG P37231 1/20 0.47
▸ HSD11B1 P28845 1/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ CA12 O43570 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ HDAC3 O15379 1/20 0.45
▸ HDAC7 Q8WUI4 1/20 0.45
▸ HDAC10 Q969S8 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1004019 0.79 HDAC1 (0.71) LMNAKMT2AMEN1L3MBTL1HDAC1
SCHEMBL3648706 0.78 NPC1 (0.55) LMNAKMT2AMEN1TSHRALDH1A1
SCHEMBL11794866 0.77 KMT2A (0.52) LMNAKMT2AMEN1L3MBTL1HDAC1
SCHEMBL1003665 0.77 KMT2A (0.83) KMT2AMEN1HDAC1HDAC6TSHR
SCHEMBL27579062 0.77 ALDH1A1 (0.55) LMNAL3MBTL1HDAC1HDAC6TSHR
SCHEMBL25138742 0.75 HDAC1 (0.71) LMNAKMT2AMEN1L3MBTL1HDAC1
SCHEMBL28204817 0.75 ALDH1A1 (0.49) LMNAL3MBTL1HDAC1HDAC6TSHR
SCHEMBL1003508 0.74 HDAC1 (0.71) LMNAKMT2AMEN1L3MBTL1HDAC1
SCHEMBL9492055 0.74 ALDH1A1 (0.63) LMNAKMT2AMEN1L3MBTL1HDAC1
SCHEMBL8586363 0.73 MLYCD (0.48) KMT2AMEN1HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010025375-A1 COMPOSITIONS AND METHODS OF TREATING AMYLOID DISEASE TREVENTIS CORPORATION (US) 2010-03-04 — — WO claimed
Send feedback